KYNTRA BIO, INC.
Ticker: 921299
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | -1.47-139.3% | 3.74+246.3% | 1.08-20.0% | 1.35-50.7% | 2.74-94.1% | 46.33-8.5% | 50.64-9.4% | 55.90 |
| Total Income | -1.47-139.3% | 3.74+246.3% | 1.08-20.0% | 1.35-50.7% | 2.74-94.1% | 46.33-8.5% | 50.64-9.4% | 55.90 |
| EXPENSES | ||||||||
| Expenditure | 16.10-8.3% | 17.56+170.6% | 6.49-51.6% | 13.40-24.1% | 17.66-72.0% | 63.11+2.5% | 61.56-29.2% | 86.97 |
| Tax | 0.00 | 0.00 | 0.00+100.0% | -0.09 | 0.00-100.0% | 0.01+103.8% | -0.26-966.7% | 0.03 |
| PROFIT | ||||||||
| PBT | 11.97+179.1% | -15.13-15.1% | -13.15+4.6% | -13.78+17.8% | -16.76+6.7% | -17.97-5.8% | -16.98+49.3% | -33.49 |
| Net Profit | 11.97+178.8% | -15.20-107.6% | 200.64+2740.0% | -7.60-263.8% | 4.64+127.2% | -17.08-9.9% | -15.54+52.8% | -32.93 |
| KEY METRICS | ||||||||
| OPM % | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00%-63.79pp | -36.21%-14.65pp | -21.56%+34.00pp | -55.57% |
| NPM % | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-200.00pp | 100.00%+136.87pp | -36.87%-6.18pp | -30.69%+28.22pp | -58.91% |
| EPS | 2.96+178.7% | -3.76-107.6% | 49.61+2738.8% | -1.88-3860.0% | 0.05+129.4% | -0.17-6.3% | -0.16+51.5% | -0.33 |
Corporate Events
Board MeetingKYNB
20261Oct
Board Meeting
Andrew E. Singer appointed as independent director and membe…
SEC Filing ↗ Board MeetingKYNB
202612Jun
Board Meeting
Annual meeting of stockholders held to elect a Class III dir…
SEC Filing ↗